Home › Multiple Sclerosis › District of Columbia
Multiple Sclerosis clinical trials in District of Columbia
4 studies for Multiple Sclerosis are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Washington D.C.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06433752An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Washington D.C.
RecruitingPhase 1
Ages 18 to 60 · All sexes · Updated Aug 25, 2026 · NCT07224373A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Georgetown University Hospital, Washington D.C.
- Medstar Washington Hosp Ctr, Washington D.C.
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.